(Q48631388)

13 February 2018

title

Inhibition of phosphodiesterase by dihydroergotamine and hydergine in various organs of the cat in vitro. (English)

1 reference

13 February 2018

author name string

R Iwangoff

series ordinal

1

1 reference

13 February 2018

A Enz

series ordinal

2

1 reference

13 February 2018

publication date

1 September 1973

1 reference

13 February 2018

published in

Experientia

1 reference

13 February 2018

volume

29

1 reference

13 February 2018

page(s)

1067-1069

1 reference

13 February 2018

issue

9

1 reference

13 February 2018

Cyclic 3 ', 5 '-nucleotide phosphodiesterase. Effect of divalent cations.

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01946723

Properties of cyclic 3',5'-nucleotide phosphodiesterase from rat brain

21 January 2018

1 reference

12 December 2020

Cyclic 3',5'-nucleotide phosphodiesterase. Demonstration of an activator.

1 reference

12 December 2020

The influence of various dihydroergotamine analogues on cyclic adenosine-3',5'-monophosphate phosphodiesterase in the grey matter of cat brain in vitro.

1 reference

12 December 2020

Different sensitivities of the phosphodiesterases (adenosine-3',5'-cyclic phosphate 3'-phosphohydrolase) of dog cerebral cortex and erythrocytes to inhibition by synthetic agents and cold.

1 reference

12 December 2020

1-Ethyl-4-(isopropylidenehydrazino)-1H-pyrazolo-(3,4-b)-pyridine-5-carboxylic acid, ethyl ester, hydrochloride (SQ 20009)--a potent new inhibitor of cyclic 3',5'-nucleotide phosphodiesterases

1 reference

12 December 2020

Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission

1 reference

12 December 2020

Assay of phosphodiesterase with radioactively labeled cyclic 3',5'-AMP as substrate

1 reference

12 December 2020

The effect of dihydroergotamine on the phosphodiesterase activity of cat grey matter.

1 reference

12 December 2020

[On the mechanism of the cardiac effects of 2-bromo-LSD]

1 reference

12 December 2020

Human brain and platelet cyclic adenosine 3',5'-monophosphate phosphodiesterases: different response to drugs.

1 reference

12 December 2020

Adenosine 3',5'-monophosphate: electrophysiological evidence for a role in synaptic transmission

1 reference

12 December 2020

Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues.

1 reference

12 December 2020

3':5'-cyclic nucleotide phosphodiesterases in rat tissues.

1 reference

12 December 2020

Adenosine 3'5'-monophosphate phosphodiesterase: multiple molecular forms.

1 reference

12 December 2020

Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine

1 reference

12 December 2020

Effect of quazodine on phosphodiesterase.

1 reference

12 December 2020

Cyclic 3'.5'-nucleotide phosphodiesterase. Effect of binding protein on the hydrolysis of cyclic AMP

1 reference

12 December 2020

New inhibitor of phosphodiesterase with anti-bronchoconstrictor properties.

1 reference

12 December 2020

Cyclic 3',5'-nucleotide phosphodiesterase: cytochemical localization in cerebral cortex.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01946723

1 reference

13 February 2018

PubMed ID

4355415

1 reference

13 February 2018